T1	Participants 333 423	Forty-nine chemotherapy-naive patients were randomized to 5-FU alone or to the combination
T2	Participants 119 331	This study compared the efficacy and safety of 5-fluorouracil (5-FU) monotherapy to that of 5-FU combined with natural human interferon-beta (IFN-beta) in patients with unresectable, advanced colorectal carcinoma
T3	Participants 745 827	Clinical endpoints were tumor response, time to progression, survival and toxicity
T4	Participants 1392 1468	The only grade IV toxicity observed was neutropenia (two patients per group)
